Dr. Rachel Yung, MD
Claim this profileUniversity of Washington Fred Hutchinson Cancer Care
Studies Breast Cancer
Studies Brain Tumor
3 reported clinical trials
7 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
Stage II
2Brain Tumor
Stage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Rachel Yung, MD is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
More about Rachel Yung, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Rachel Yung, MD has experience with
- Margetuximab
- Paclitaxel
- Pertuzumab
- Trastuzumab
- Carvedilol
- Adjuvant Chemotherapy + Ovarian Function Suppression
Breakdown of trials Rachel Yung, MD has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rachel Yung, MD specialize in?
Rachel Yung, MD focuses on Breast Cancer and Brain Tumor. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Rachel Yung, MD currently recruiting for clinical trials?
Yes, Rachel Yung, MD is currently recruiting for 2 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Rachel Yung, MD has studied deeply?
Yes, Rachel Yung, MD has studied treatments such as Margetuximab, Paclitaxel, Pertuzumab.
What is the best way to schedule an appointment with Rachel Yung, MD?
Apply for one of the trials that Rachel Yung, MD is conducting.
What is the office address of Rachel Yung, MD?
The office of Rachel Yung, MD is located at: University of Washington Fred Hutchinson Cancer Care, Seattle, Washington 98109 United States. This is the address for their practice at the University of Washington Fred Hutchinson Cancer Care.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.